Relative Strength Chart Cardiol Therapeutics Inc.

Stocks

Delayed Toronto S.E. 18:14:24 02/10/2026 +04			5-day change	1st Jan Change
2.290 ^CAD	+2.69%		-6.17%	+74.05%

09-23	Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead of Schedule and Expands Pivotal Trial	CI
09-23	Cardiol Therapeutics Inc. Achieves MAVERIC Enrollment Target And Expands Pivotal Trial Evaluating CardiolRx	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	CARDIOL THERAPEUTICS INC.	Other Biotechnology & Medical Research	+2.69%	-6.17%	+74.05%	+57.24%	-48.76%	183M